Literature DB >> 8788376

A missense mutation in the beta-myosin heavy chain gene in a Japanese patient with hypertrophic cardiomyopathy.

C Nakajima-Taniguchi1, J Azuma, S Nagata, T Kishimoto, K Yamauchi-Takihara.   

Abstract

A 55-year-old man had been previously admitted at the age of 44 because of chest pain on effort. He was diagnosed as hypertrophic obstructive cardiomyopathy with a left ventricular outflow pressure gradient of 65 mmHg. We analyzed the cardiac beta-myosin heavy chain gene in this patient using polymerase chain reaction-single strand conformation polymorphism analysis (PCR-SSCP analysis). PCR-SSCP analysis revealed a sequence variation within exon 16. A G-to-A transversion with replacement of Val by Met at codon 606 was confirmed by sequencing analysis. Previously, a 606Val-->Met mutation has been reported to give a benign prognosis because of the neutral charge substitution. However, there have been some premature deaths in this patient's kindred. Thus, despite the absence of a change in charge, this mutation may be malignant in some kindreds.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8788376     DOI: 10.1253/jcj.59.833

Source DB:  PubMed          Journal:  Jpn Circ J        ISSN: 0047-1828


  3 in total

1.  Genotype phenotype correlations of cardiac beta-myosin heavy chain mutations in Indian patients with hypertrophic and dilated cardiomyopathy.

Authors:  Taranjit Singh Rai; Shamim Ahmad; Ajay Bahl; Monica Ahuja; Tarunveer Singh Ahluwalia; Balvinder Singh; K K Talwar; Madhu Khullar
Journal:  Mol Cell Biochem       Date:  2008-10-25       Impact factor: 3.396

2.  Genetic variations of β-MYH7 in hypertrophic cardiomyopathy and dilated cardiomyopathy.

Authors:  Reena Tanjore; Advithi Rangaraju; Shivani Vadapalli; Sushant Remersu; Calambur Narsimhan; Pratibha Nallari
Journal:  Indian J Hum Genet       Date:  2010-05

Review 3.  Hypertrophic cardiomyopathy: how do mutations lead to disease?

Authors:  Júlia Daher Carneiro Marsiglia; Alexandre Costa Pereira
Journal:  Arq Bras Cardiol       Date:  2014-03       Impact factor: 2.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.